Stock Report

Suven Lifesciences Ltd consolidated Q4FY23 loss at Rs. 27.64 crores

Posted On : 2023-05-09 18:12:29( TIMEZONE : IST )

Suven Life Sciences Limited has reported Consolidated financial results for the period ended March 31, 2023.

Financial Results (Q4 FY2023) - QoQ Comparison

The company has reported total income of Rs. 8.2133 crores during the period ended March 31, 2023 as compared to Rs. 5.2073 crores during the period ended December 31, 2022.

The company has posted net profit / (loss) of Rs. -27.6449 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs. -51.1152 crores for the period ended December 31, 2022.

The company has reported EPS of Rs. -1.17 for the period ended March 31, 2023 as compared to Rs. -2.90 for the period ended December 31, 2022.

Financials	Q4 FY2023	Q3 FY2023	% Change
Total Income	₹8.2133 crs	₹5.2073 crs	57.73%
Net Profit	₹-27.6449 crs	₹-51.1152 crs	45.92%
EPS	₹-1.17	₹-2.90	59.66%

Financial Results (Q4 FY2023) - YoY Comparison

The company has reported total income of Rs.8.2133 crores during the period ended March 31, 2023 as compared to Rs.4.3395 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs.-27.6449 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs.-20.7981 crores for the period ended March 31, 2022.

The company has reported EPS of Rs.-1.17 for the period ended March 31, 2023 as compared to Rs.-1.63 for the period ended March 31, 2022.

Financials	Q4 FY2023	Q4 FY2022	% Change
Total Income	₹8.2133 crs	₹4.3395 crs	89.27%
Net Profit	₹-27.6449 crs	₹-20.7981 crs	32.92%
EPS	₹-1.17	₹-1.63	28.22%

Financial Results (Year Ended FY2023) - YoY Comparison

The company has reported total income of Rs.21.9882 crores during the Financial Year ended March 31, 2023 as compared to Rs.13.4457 crores during the Financial Year ended March 31, 2022.

The company has posted net profit / (loss) of Rs.-118.2678 crores for the Financial Year ended March 31, 2023 as against net profit / (loss) of Rs.-121.9951 crores for the Financial Year ended March 31, 2022.

The company has reported EPS of Rs.-6.63 for the Financial Year ended March 31, 2023 as compared to Rs.-9.05 for the Financial Year ended March 31, 2022.

Financials	Year Ended FY2023	Year Ended FY2022	% Change
Total Income	₹21.9882 crs	₹13.4457 crs	63.53%
Net Profit	₹-118.2678 crs	₹-121.9951 crs	3.06%
EPS	₹-6.63	₹-9.05	26.74%

Shares of Suven Life Sciences Limited was last trading in BSE at Rs. 57.98 as compared to the previous close of Rs. 59.42. The total number of shares traded during the day was 20741 in over 363 trades.

The stock hit an intraday high of Rs. 61.18 and intraday low of 57.25. The net turnover during the day was Rs. 1231601.00.